New research shows that the QL1101, structurally similar to an existing cancer drug, is a safe and effective alternative for lung cancer treatment. In 2018, lung cancer caused 1.8 million cancer deaths worldwide. It is the most common type of cancer, with non-small cell lung cancers (NSCLCs) accounting for 85% of lung cancers. Most recent lung cancer research focuses...
